Physician
David Lecusay Pediatrics P a
David Lecusay Pediatrics P a was paid $2.68M by Medicaid between Feb 2020 and Nov 2024, across 62 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.
33Billing provider infoDAVID LECUSAY PEDIATRICS P A
BROWNSVILLE, TX 78520
BROWNSVILLE, TX 78520
33aNPI1306088562assigned 04/01/2009
33bProvider typePediatrics Physician
28Total paid$2.68M
24GClaims146,026
24DCodes billed62
24AFirst – last monthFeb 2020 – Nov 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#176 of 1,136
Median peer was paid$329K
This provider vs. median8.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 4,309 | $84K | |
| 2021 | 22,821 | $418K | |
| 2022 | 44,645 | $772K | |
| 2023 | 44,460 | $832K | |
| 2024incomplete | 29,791 | $570K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 35,593 | 31,064 | $789K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 14% | 9,819 | 9,336 | $379K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 12% | 4,235 | 4,181 | $321K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 10% | 3,827 | 3,768 | $271K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 9.5% | 3,540 | 3,494 | $253K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.1% | 2,828 | 2,732 | $190K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.8% | 9,944 | 9,764 | $102K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.6% | 7,305 | 3,456 | $69K |
| 99429 | 2.3% | 2,510 | 2,476 | $62K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.1% | 5,200 | 4,994 | $57K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 6,286 | 5,862 | $29K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,736 | 2,893 | $21K |
50 more codes
| 99000 | <1% | 4,473 | $21K | |
| 83655 | <1% | 2,332 | $18K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,317 | $16K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 3,100 | $15K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 359 | $14K |
| 90461 | <1% | 4,840 | $8K | |
| 0001A | <1% | 250 | $8K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 578 | $5K |
| 96160 | <1% | 3,176 | $4K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 112 | $4K |
| 0072A | <1% | 91 | $3K | |
| 87807 | <1% | 345 | $3K | |
| 99381 | <1% | 38 | $3K | |
| 86580 | <1% | 478 | $2K | |
| 0071A | <1% | 49 | $2K | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 568 | $1K |
| 0081A | <1% | 16 | $640.00 | |
| 90670 | <1% | 1,312 | $635.84 | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 12 | $571.92 |
| 81003 | <1% | 292 | $332.64 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 423 | $310.48 |
| 94010 | <1% | 14 | $247.80 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 106 | $161.59 |
| 90688 | <1% | 3,953 | $76.32 | |
| 90648 | <1% | 343 | $36.55 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 146 | $22.41 |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 169 | $5.00 |
| G9273 | Blood pressure has a systolic value of < 140 and a diastolic value of < 90 | <1% | 7,164 | $3.50 |
| 96161 | <1% | 105 | $2.07 | |
| 90671 | <1% | 798 | $0.95 | |
| 90651 | <1% | 1,191 | $0.60 | |
| 90677 | <1% | 142 | $0.06 | |
| 90620 | <1% | 142 | $0.03 | |
| 90680 | <1% | 1,293 | $0.01 | |
| 90734 | 0% | 699 | $0.00 | |
| 90633 | 0% | 895 | $0.00 | |
| 91308 | 0% | 75 | $0.00 | |
| 90710 | 0% | 179 | $0.00 | |
| 90700 | 0% | 69 | $0.00 | |
| 91300 | 0% | 250 | $0.00 | |
| 90715 | 0% | 60 | $0.00 | |
| 90707 | 0% | 75 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 6,222 | $0.00 |
| 90697 | 0% | 817 | $0.00 | |
| 90698 | 0% | 293 | $0.00 | |
| 90696 | 0% | 160 | $0.00 | |
| 90716 | 0% | 62 | $0.00 | |
| 91307 | 0% | 463 | $0.00 | |
| 90723 | 0% | 62 | $0.00 | |
| D1208 | Topical application of fluoride, excluding varnish | 0% | 95 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLECUSAY, DAVID (MD / PRESIDENT)